Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting

被引:0
|
作者
Fautrel, Bruno [1 ,2 ]
Assing, Maryse [3 ]
Mammar, Nadir [3 ]
Brault, Yves [3 ]
Marotte, Hubert [4 ]
机构
[1] Sorbonne Univ, Paris, France
[2] Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France
[3] Pfizer, Paris, France
[4] INSERM 1059, St Etienne, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1426
引用
收藏
页码:2810 / 2812
页数:3
相关论文
共 50 条
  • [1] Year-two follow-up results of an observational study conducted in Crohn's disease and ulcerative colitis patients treated with infliximab biosimilar CT-P13 in a real-life setting
    Laharie, D.
    Pierron, G.
    Brault, Y.
    Bouhnik, Y.
    Nancey, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 658 - 659
  • [2] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [3] Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1763 - 1769
  • [4] BIOSIMILAR INFLIXIMAB THERAPY IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS:A LONG-TERM FOLLOW-UP STUDY ON INFLIXIMAB-NAIVE PATIENTS AND PATIENTS SWITCHED FROM THE ORIGINATORTO THE BIOSIMILAR CT-P13
    Fautrel, B.
    Assing, M.
    Mammar, N.
    Marotte, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 529 - 530
  • [5] Effectiveness and Safety of CT-P13 (Biosimilar Reference Infliximab) in a Real-Life Setting in 151 Patients with Rheumatoid Arthritis and Ankylosing Spondylitis: A Mid-Term Interim Analysis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
    Kurizky, Patricia Shu
    Galvao, Leticia Oba
    Martins, Gladys Aires
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (04) : 483 - 484
  • [7] EFFECTIVENESS AND SAFETY OF CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS AND PLAQUE PSORIASIS: OBSERVATIONAL STUDY IN REPUBLIC OF KOREA
    Kim, D. -W.
    Kim, T. -H.
    Kwon, S. R.
    Lee, E. Y.
    Son, C. -N.
    Kim, Y. S.
    Kim, S. H.
    Park, Y. -B.
    Hur, J. -W.
    Lee, H. -S.
    Lee, S. J.
    Lee, S. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 827 - 828
  • [8] Effectiveness and Safety of CT-P13 in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis: Observational Study in Republic of Korea
    Kim, Dong-Wook
    Kim, Tae-Hwan
    Kwon, Seong Ryul
    Lee, Eun Young
    Son, Chang-Nam
    Kim, Yun Sung
    Kim, Soung Hun
    Park, Yong-Beom
    Hur, Jin-Wuk
    Lee, Hye-Soon
    Lee, Sang Joon
    Suh, Jee Hye
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] Biosimilar Infliximab Therapy in Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis: A Long-term Follow-up Study on Infliximab-naive Patients and Switched Patients from the Originator to the Biosimilar CT-P13
    Marotte, Hubert
    Assing, Maryse
    Mammar, Nadir
    Brault, Yves
    Fautrel, Bruno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1683 - 1685
  • [10] A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Kim, Tae-Hwan
    Lee, Shin-Seok
    Park, Won
    Song, Yeong Wook
    Suh, Chang-Hee
    Kim, Sookyoung
    Lee, Youngnam
    Yoo, DaeHyun
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1159 - 1160